Literature DB >> 12386351

Five-year follow-up of patients participating in a randomized trial of uterine balloon therapy versus rollerball ablation for treatment of menorrhagia.

Franklin D Loffer1, David Grainger.   

Abstract

STUDY
OBJECTIVE: To collect long-term follow-up information from women who participated in a randomized trial comparing uterine balloon therapy (UBT; Gynecare, Somerville, NJ) with rollerball ablation for treatment of menorrhagia.
DESIGN: Five-year contact of participants treated in a 1996 multicenter, randomized trial (Canadian Task Force classification I).
SETTING: Twelve North American university and private practice centers. PATIENTS: Women treated with endometrial ablation for menorrhagia who were available for 5-year follow-up. INTERVENTION: Uterine balloon therapy or rollerball ablation.
MEASUREMENTS AND MAIN RESULTS: Of 255 women treated under the original protocol, 147 were available to be interviewed 5 years after the procedure. Of these, 25 patients reported hysterectomy, repeat ablation, or dilatation and curettage (D&C) between years 3 and 5, leaving 122 eligible for analysis (61 UBT, 61 rollerball). Of these 122 patients, 58 (95%) having UBT and 59 (97%) having rollerball ablation reported normal or less bleeding. Similarly, 93% and 100%, respectively, were satisfied with the procedure. Among the total population of 255 women, 42 hysterectomies (21 UBT, 21 rollerball), 5 repeat ablations (3 UBT, 2 rollerball), and 1 D&C (rollerball) were reported by year 5. Thirty-five hysterectomies (83%) were performed because of bleeding and/or pelvic pain; one-third of them were associated with myomas. Nearly 7 of 10 women were cured of menorrhagia without additional intervention 5 years after ablation.
CONCLUSION: UBT continues to be an effective, simple treatment of menorrhagia, with clinical outcomes similar to those of rollerball ablation at 5-year follow-up.

Entities:  

Mesh:

Year:  2002        PMID: 12386351     DOI: 10.1016/s1074-3804(05)60514-2

Source DB:  PubMed          Journal:  J Am Assoc Gynecol Laparosc        ISSN: 1074-3804


  7 in total

1.  Uterine Balloon Therapy : An Alternative Therapy for Menorrhagia.

Authors:  K Kapur; G S Joneja; M Biswas
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  Ambulatory management of heavy menstrual bleeding.

Authors:  Attilio Di Spiezio Sardo; Marialuigia Spinelli; Brunella Zizolfi; Carmine Nappi
Journal:  Womens Health (Lond)       Date:  2015-12-23

3.  Outpatient Thermachoice endometrial balloon ablation: long-term, prognostic and quality-of-life measures.

Authors:  Rajesh Varma; Hemi Soneja; Nadia Samuel; Eki Sangha; Thomas Justin Clark; Janesh K Gupta
Journal:  Gynecol Obstet Invest       Date:  2010-06-16       Impact factor: 2.031

Review 4.  Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.

Authors:  L J Middleton; R Champaneria; J P Daniels; S Bhattacharya; K G Cooper; N H Hilken; P O'Donovan; M Gannon; R Gray; K S Khan; J Abbott; J Barrington; S Bhattacharya; M Y Bongers; J-L Brun; R Busfield; M Sowter; T J Clark; J Cooper; K G Cooper; S L Corson; K Dickersin; N Dwyer; M Gannon; J Hawe; R Hurskainen; W R Meyer; H O'Connor; S Pinion; A M Sambrook; W H Tam; I A A van Zon-Rabelink; E Zupi
Journal:  BMJ       Date:  2010-08-16

5.  Prediction of treatment outcomes after global endometrial ablation.

Authors:  Sherif A El-Nashar; Matthew R Hopkins; Douglas J Creedon; Jennifer L St Sauver; Amy L Weaver; Michaela E McGree; William A Cliby; Abimbola O Famuyide
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

Review 6.  Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis.

Authors:  J P Daniels; L J Middleton; R Champaneria; K S Khan; K Cooper; B W J Mol; S Bhattacharya
Journal:  BMJ       Date:  2012-04-23

7.  Thermal balloon endometrial ablation in the treatment of heavy menstrual bleeding.

Authors:  Zinatossadat Bouzari; Shahla Yazdani; Samira Azimi; Mouloud Agajani Delavar
Journal:  Med Arch       Date:  2014-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.